董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Tullio Panarello | 男 | Director | -- | 未披露 | 未持股 | 2026-03-31 |
| Francis Bellido | 男 | Chief Executive Officer and Director and President | -- | 未披露 | 未持股 | 2026-03-31 |
| David Wayne Teeple | 男 | Director | -- | 未披露 | 未持股 | 2026-03-31 |
| Edward Larry Moore | 男 | Chief Technical Officer and Director | -- | 未披露 | 未持股 | 2026-03-31 |
| John Young | 男 | Chief Operating Officer and Director | -- | 未披露 | 未持股 | 2026-03-31 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Marc Rousseau | 男 | Chief Financial Officer | -- | 未披露 | 未持股 | 2026-03-31 |
| Francis Bellido | 男 | Chief Executive Officer and Director and President | -- | 未披露 | 未持股 | 2026-03-31 |
| Edward Larry Moore | 男 | Chief Technical Officer and Director | -- | 未披露 | 未持股 | 2026-03-31 |
| John Young | 男 | Chief Operating Officer and Director | -- | 未披露 | 未持股 | 2026-03-31 |
董事简历
中英对照 | 中文 | 英文- Tullio Panarello
-
Tullio Panarello过去25年曾在电信、军事、半导体、太空和传感器行业的多家高科技公司担任多个高级领导职务。他的技术和市场知识延伸到激光、光学、半导体和基于量子的技术领域。他目前担任魁北克省蒙特利尔Smiths Interconnect的副总裁兼总经理，该公司收购了他担任执行总裁的ReflexPhotonics公司。在其职业生涯的早期，他曾在珀金埃尔默加拿大公司担任业务发展经理，之后共同创立了PyroPhotonics Lasers Inc.，这是一家专门从事用于材料加工应用的脉冲激光技术的公司。他成为PyroPhotonics的首席执行官，直到将其出售给电子科技工业（ESI），后来他担任激光业务事业部的部门总经理。
Tullio Panarello has served in several senior leadership roles over the past 25 years in many high tech companies across the telecom, military, semiconductor, space, and sensor industries. His technical and market knowledge extends to the fields of lasers, optics, semiconductors, and quantum based technologies. He is currently Vice President and General Manager at Smiths Interconnect in Montreal, Quebec, which acquired ReflexPhotonics, the company where he served as Executive President. Earlier in his career, he worked as Business Development Manager for PerkinElmer Canada before co founding PyroPhotonics Lasers Inc., a company specializing in pulsed laser technology for material processing applications. He became CEO of PyroPhotonics until its sale to Electro Scientific Industries (ESI), where he later served as Divisional General Manager for the Laser Business Division. - Tullio Panarello过去25年曾在电信、军事、半导体、太空和传感器行业的多家高科技公司担任多个高级领导职务。他的技术和市场知识延伸到激光、光学、半导体和基于量子的技术领域。他目前担任魁北克省蒙特利尔Smiths Interconnect的副总裁兼总经理，该公司收购了他担任执行总裁的ReflexPhotonics公司。在其职业生涯的早期，他曾在珀金埃尔默加拿大公司担任业务发展经理，之后共同创立了PyroPhotonics Lasers Inc.，这是一家专门从事用于材料加工应用的脉冲激光技术的公司。他成为PyroPhotonics的首席执行官，直到将其出售给电子科技工业（ESI），后来他担任激光业务事业部的部门总经理。
- Tullio Panarello has served in several senior leadership roles over the past 25 years in many high tech companies across the telecom, military, semiconductor, space, and sensor industries. His technical and market knowledge extends to the fields of lasers, optics, semiconductors, and quantum based technologies. He is currently Vice President and General Manager at Smiths Interconnect in Montreal, Quebec, which acquired ReflexPhotonics, the company where he served as Executive President. Earlier in his career, he worked as Business Development Manager for PerkinElmer Canada before co founding PyroPhotonics Lasers Inc., a company specializing in pulsed laser technology for material processing applications. He became CEO of PyroPhotonics until its sale to Electro Scientific Industries (ESI), where he later served as Divisional General Manager for the Laser Business Division.
- Francis Bellido
-
Francis Bellido在网络安全、医疗保健和金融行业拥有超过36年的国际经验。他在2015年至2018年担任CFO后，于2018年至2020年担任SoundBite Medical的CEO。从2007年到2014年，他在大型、中型和初创公司担任过多个高管职位。从1999年到2006年，他管理了3亿美元的生命科学投资基金（SGF Sant é），并为Cryocath、IDI GeneOHM、Draxis、Medicago、Atrium和Axcan Pharma等大公司的成功做出了贡献。他还曾在美国和欧洲的礼来担任多个高管职位，包括战略资产总监、全球业务部门经理和监管事务主管。除了担任公司职务外，他还是蒙特利尔魁北克大学生物工业管理系主任，在那里他担任了15年的管理学院特邀教授一职。Bellido博士曾在20多家私营和上市公司担任董事会成员和董事。他目前是Diagnos（ADK.V）、Magneceuticals（USA）和RegenLab（CH）的董事会成员。他还是世界领先的生物制药CMO之一DSM Biologics Company Inc.的前董事会成员。他拥有瑞士日内瓦大学MBA、药学理学硕士学位和科学博士学位。他还在同行评审的科学期刊上发表了40多篇原创手稿和通讯。
Francis Bellido has over 36 years of international experience in Cybersecurity, Healthcare and Financial industries. He was the CEO of SoundBite Medical from 2018 to 2020 after serving as CFO from 2015 to 2018. From 2007 to 2014, he held several top executive positions in large, medium sized and start up companies. From 1999 to 2006, he managed a $300M life science investment fund (SGF Santé) and contributed to the success of major companies such as Cryocath, IDI GeneOhm, Draxis, Medicago, Atrium and Axcan Pharma. He also occupied several executive positions with Eli Lilly in the United States and Europe, including Strategic Asset Director, Global Business Unit Manager and Head of Regulatory Affairs. In addition to his corporate roles, he was Director of the Chair of Management in Bioindustry at the University of Quebec in Montreal, where he held the position of Invited Professor at the School of Management for 15 years. Dr. Bellido has served as Board Member and Director in more than 20 private and public companies. He currently sits on the boards of Diagnos (ADK.V), Magneceuticals (USA) and RegenLab (CH). He is also a former board member of DSM Biologics Company Inc., one of the world's leading biopharmaceutical CMOs. He holds an MBA, an MSc in Pharmaceutical Sciences and a PhD in Sciences from the University of Geneva, Switzerland. He has also published over 40 original manuscripts and communications in peer reviewed scientific journals. - Francis Bellido在网络安全、医疗保健和金融行业拥有超过36年的国际经验。他在2015年至2018年担任CFO后，于2018年至2020年担任SoundBite Medical的CEO。从2007年到2014年，他在大型、中型和初创公司担任过多个高管职位。从1999年到2006年，他管理了3亿美元的生命科学投资基金（SGF Sant é），并为Cryocath、IDI GeneOHM、Draxis、Medicago、Atrium和Axcan Pharma等大公司的成功做出了贡献。他还曾在美国和欧洲的礼来担任多个高管职位，包括战略资产总监、全球业务部门经理和监管事务主管。除了担任公司职务外，他还是蒙特利尔魁北克大学生物工业管理系主任，在那里他担任了15年的管理学院特邀教授一职。Bellido博士曾在20多家私营和上市公司担任董事会成员和董事。他目前是Diagnos（ADK.V）、Magneceuticals（USA）和RegenLab（CH）的董事会成员。他还是世界领先的生物制药CMO之一DSM Biologics Company Inc.的前董事会成员。他拥有瑞士日内瓦大学MBA、药学理学硕士学位和科学博士学位。他还在同行评审的科学期刊上发表了40多篇原创手稿和通讯。
- Francis Bellido has over 36 years of international experience in Cybersecurity, Healthcare and Financial industries. He was the CEO of SoundBite Medical from 2018 to 2020 after serving as CFO from 2015 to 2018. From 2007 to 2014, he held several top executive positions in large, medium sized and start up companies. From 1999 to 2006, he managed a $300M life science investment fund (SGF Santé) and contributed to the success of major companies such as Cryocath, IDI GeneOhm, Draxis, Medicago, Atrium and Axcan Pharma. He also occupied several executive positions with Eli Lilly in the United States and Europe, including Strategic Asset Director, Global Business Unit Manager and Head of Regulatory Affairs. In addition to his corporate roles, he was Director of the Chair of Management in Bioindustry at the University of Quebec in Montreal, where he held the position of Invited Professor at the School of Management for 15 years. Dr. Bellido has served as Board Member and Director in more than 20 private and public companies. He currently sits on the boards of Diagnos (ADK.V), Magneceuticals (USA) and RegenLab (CH). He is also a former board member of DSM Biologics Company Inc., one of the world's leading biopharmaceutical CMOs. He holds an MBA, an MSc in Pharmaceutical Sciences and a PhD in Sciences from the University of Geneva, Switzerland. He has also published over 40 original manuscripts and communications in peer reviewed scientific journals.
- David Wayne Teeple
-
David Wayne Teeple相关的技术和业务知识以及重要的网络，这是他在电信、信息技术/管理（IT或IM）和信息安全系统的30年任期内开发的。在加拿大军队任职期间，作为通信与电子项目/项目管理官员，以及在信息技术行业，他获得了在各种行政职位上的经验。他是Phirelight Security Solutions Inc.的创始人和首席执行官，该公司于2018年12月被一家提供空间和安全工程服务和技术的大型国际公司收购。他目前是他们的网络安全顾问之一。他拥有渥太华大学计算机科学学位。
David Wayne Teeple relevant technical and business knowledge and a significant network, which he developed during his 30 year tenure in telecommunications, information technology/management (IT or IM), and information security systems. During his years in the Canadian Military, as a Communications & Electronics Program/Project Management Officer, and in the Information Technology industry, he acquired experience in a wide variety of executive positions. He was the founder and CEO of Phirelight Security Solutions Inc., which was acquired in December 2018 by a large international company offering space and security engineering services and technologies. He is currently one of their Cybersecurity Advisors. He holds a degree in computer science from the University of Ottawa. - David Wayne Teeple相关的技术和业务知识以及重要的网络，这是他在电信、信息技术/管理（IT或IM）和信息安全系统的30年任期内开发的。在加拿大军队任职期间，作为通信与电子项目/项目管理官员，以及在信息技术行业，他获得了在各种行政职位上的经验。他是Phirelight Security Solutions Inc.的创始人和首席执行官，该公司于2018年12月被一家提供空间和安全工程服务和技术的大型国际公司收购。他目前是他们的网络安全顾问之一。他拥有渥太华大学计算机科学学位。
- David Wayne Teeple relevant technical and business knowledge and a significant network, which he developed during his 30 year tenure in telecommunications, information technology/management (IT or IM), and information security systems. During his years in the Canadian Military, as a Communications & Electronics Program/Project Management Officer, and in the Information Technology industry, he acquired experience in a wide variety of executive positions. He was the founder and CEO of Phirelight Security Solutions Inc., which was acquired in December 2018 by a large international company offering space and security engineering services and technologies. He is currently one of their Cybersecurity Advisors. He holds a degree in computer science from the University of Ottawa.
- Edward Larry Moore
-
Edward Larry Moore创立了ANACAD，该公司开发了集成电路（IC）设计的软件技术。ANACAD的产品在IC设计中的应用被全球采用，并被戴姆勒、东芝、SGS汤姆森等大公司所采用。该公司最终被出售给了明导资讯。Moore博士目前是Baystream的总裁，该公司是一家专注于过程自动化和基于云的解决方案的公司。最近，Baystream开发了自动化解决方案，将专注于可用性和合规性的安全强化系统部署到云上，从而加强了其流程自动化产品及其在市场上的关键地位。
Edward Larry Moore founded ANACAD, which developed software technology for integrated circuit (IC) design. ANACAD's products were adopted globally for their application in IC design and utilized by major corporations such as Daimler, Toshiba, and SGS Thomson. The company was eventually sold to Mentor Graphics. Dr. Moore is currently President of Baystream, a company specializing in process automation and cloud based solutions. Recently, Baystream developed automation solutions to deploy security hardened systems to the Cloud that are focused on availability and compliance, strengthening its process automation offering and its key position in the market. - Edward Larry Moore创立了ANACAD，该公司开发了集成电路（IC）设计的软件技术。ANACAD的产品在IC设计中的应用被全球采用，并被戴姆勒、东芝、SGS汤姆森等大公司所采用。该公司最终被出售给了明导资讯。Moore博士目前是Baystream的总裁，该公司是一家专注于过程自动化和基于云的解决方案的公司。最近，Baystream开发了自动化解决方案，将专注于可用性和合规性的安全强化系统部署到云上，从而加强了其流程自动化产品及其在市场上的关键地位。
- Edward Larry Moore founded ANACAD, which developed software technology for integrated circuit (IC) design. ANACAD's products were adopted globally for their application in IC design and utilized by major corporations such as Daimler, Toshiba, and SGS Thomson. The company was eventually sold to Mentor Graphics. Dr. Moore is currently President of Baystream, a company specializing in process automation and cloud based solutions. Recently, Baystream developed automation solutions to deploy security hardened systems to the Cloud that are focused on availability and compliance, strengthening its process automation offering and its key position in the market.
- John Young
-
约翰·杨看电影《能抓住我就抓住我》十几岁的时候，三年时间里，约翰·杨和他的电信系统专家导师、已故的D.F.鲁尼，成功地入侵了美国电话电报网络——直到FBI吓得他直接进入了40年的网络安全生涯。作为麦道价值410亿美元的C17项目的前网络总监，约翰后来在IBM工作了几十年后退休，随后成为全球仅有的11位获得全部9项ISC2认证的网络安全专家之一。于2024年6月被任命为QEM的董事会成员。
John Young see the movie Catch Me If You Can As a teenager, for three years John Young and his expert telecommunications systems mentor, the late D.F. Rooney, successfully hacked the AT&T network—until the FBI scared him straight into a 40 year cybersecurity career. The former network director of McDonnell Douglas's $41 billion C 17 program, John later retired after decades at IBM and then became one of only 11 cybersecurity experts worldwide to earn all nine ISC2 certifications. Named to the board of directors at QeM in June 2024. - 约翰·杨看电影《能抓住我就抓住我》十几岁的时候，三年时间里，约翰·杨和他的电信系统专家导师、已故的D.F.鲁尼，成功地入侵了美国电话电报网络——直到FBI吓得他直接进入了40年的网络安全生涯。作为麦道价值410亿美元的C17项目的前网络总监，约翰后来在IBM工作了几十年后退休，随后成为全球仅有的11位获得全部9项ISC2认证的网络安全专家之一。于2024年6月被任命为QEM的董事会成员。
- John Young see the movie Catch Me If You Can As a teenager, for three years John Young and his expert telecommunications systems mentor, the late D.F. Rooney, successfully hacked the AT&T network—until the FBI scared him straight into a 40 year cybersecurity career. The former network director of McDonnell Douglas's $41 billion C 17 program, John later retired after decades at IBM and then became one of only 11 cybersecurity experts worldwide to earn all nine ISC2 certifications. Named to the board of directors at QeM in June 2024.
高管简历
中英对照 | 中文 | 英文- Marc Rousseau
Marc Rousseau是LVR Capital Inc.的总裁。他的职业生涯始于加拿大的Cr é dit Ford，在那里他担任运营总监。2001年，他加入加拿大商业发展银行，担任高级业务发展经理，该职位一直担任到LVR Capital于2005年9月成立。LVR是一家咨询投资银行，为企业的融资需求提供直接咨询，主要用于债务融资。自2005年以来，它在向众多公司提供近2亿美元以及负责几家公司的重组和扭亏为盈方面发挥了重要作用。同时，他在1981年至2004年期间作为加拿大部队的步兵军官从事军事生涯。他在1996年至1999年期间指挥皇家芒特燧发枪团，并在波斯尼亚担任萨拉热窝北约总部的计划和政策小组组长。卢梭先生曾担任加拿大国家电影委员会和Iscope公司的董事，并担任魁北克残疾儿童协会的董事会主席。他在Pilote Groupe Conseil和RealByFake的咨询委员会任职，为其他公司的财务战略提供咨询。他是La Fondation Les Fusiliers Mont Royal的总裁，也是Corporate Connections的成员。他拥有Concordia大学经济学文学士学位。
Marc Rousseau is the President of LVR Capital Inc. He began his professional career with Crédit Ford of Canada, where he acted as Director of Operations. In 2001, he joined the Business Development Bank of Canada as a Senior Business Development Manager, a position he held until LVR Capital was founded in September 2005. LVR is a consultation investment bank providing direct counsel to firms in their financing needs, mostly for debt financing. Since 2005, it has been instrumental in providing close to $200M to numerous companies, as well as being responsible for the restructuring and turnaround of several firms. At the same time, he pursued a military career from 1981 to 2004 as an infantry officer with the Canadian Forces. He commanded the Mount Royal Fusilliers Regiment from 1996 to 1999 and served in Bosnia as a Plans and Policy Team Leader at NATO Headquarters in Sarajevo. Mr. Rousseau has been a director of the National Film Board of Canada and of Iscope Corporation and has chaired the board of the Quebec Society for Disabled Children. He serves on the advising committee of Pilote Groupe Conseil and of RealByFake, and counsels other firms on their financial strategies. He is the President of La Fondation Les Fusiliers Mont Royal and a member of Corporate Connections. He holds a Bachelor of Arts, Economics, from Concordia University.- Marc Rousseau是LVR Capital Inc.的总裁。他的职业生涯始于加拿大的Cr é dit Ford，在那里他担任运营总监。2001年，他加入加拿大商业发展银行，担任高级业务发展经理，该职位一直担任到LVR Capital于2005年9月成立。LVR是一家咨询投资银行，为企业的融资需求提供直接咨询，主要用于债务融资。自2005年以来，它在向众多公司提供近2亿美元以及负责几家公司的重组和扭亏为盈方面发挥了重要作用。同时，他在1981年至2004年期间作为加拿大部队的步兵军官从事军事生涯。他在1996年至1999年期间指挥皇家芒特燧发枪团，并在波斯尼亚担任萨拉热窝北约总部的计划和政策小组组长。卢梭先生曾担任加拿大国家电影委员会和Iscope公司的董事，并担任魁北克残疾儿童协会的董事会主席。他在Pilote Groupe Conseil和RealByFake的咨询委员会任职，为其他公司的财务战略提供咨询。他是La Fondation Les Fusiliers Mont Royal的总裁，也是Corporate Connections的成员。他拥有Concordia大学经济学文学士学位。
- Marc Rousseau is the President of LVR Capital Inc. He began his professional career with Crédit Ford of Canada, where he acted as Director of Operations. In 2001, he joined the Business Development Bank of Canada as a Senior Business Development Manager, a position he held until LVR Capital was founded in September 2005. LVR is a consultation investment bank providing direct counsel to firms in their financing needs, mostly for debt financing. Since 2005, it has been instrumental in providing close to $200M to numerous companies, as well as being responsible for the restructuring and turnaround of several firms. At the same time, he pursued a military career from 1981 to 2004 as an infantry officer with the Canadian Forces. He commanded the Mount Royal Fusilliers Regiment from 1996 to 1999 and served in Bosnia as a Plans and Policy Team Leader at NATO Headquarters in Sarajevo. Mr. Rousseau has been a director of the National Film Board of Canada and of Iscope Corporation and has chaired the board of the Quebec Society for Disabled Children. He serves on the advising committee of Pilote Groupe Conseil and of RealByFake, and counsels other firms on their financial strategies. He is the President of La Fondation Les Fusiliers Mont Royal and a member of Corporate Connections. He holds a Bachelor of Arts, Economics, from Concordia University.
- Francis Bellido
Francis Bellido在网络安全、医疗保健和金融行业拥有超过36年的国际经验。他在2015年至2018年担任CFO后，于2018年至2020年担任SoundBite Medical的CEO。从2007年到2014年，他在大型、中型和初创公司担任过多个高管职位。从1999年到2006年，他管理了3亿美元的生命科学投资基金（SGF Sant é），并为Cryocath、IDI GeneOHM、Draxis、Medicago、Atrium和Axcan Pharma等大公司的成功做出了贡献。他还曾在美国和欧洲的礼来担任多个高管职位，包括战略资产总监、全球业务部门经理和监管事务主管。除了担任公司职务外，他还是蒙特利尔魁北克大学生物工业管理系主任，在那里他担任了15年的管理学院特邀教授一职。Bellido博士曾在20多家私营和上市公司担任董事会成员和董事。他目前是Diagnos（ADK.V）、Magneceuticals（USA）和RegenLab（CH）的董事会成员。他还是世界领先的生物制药CMO之一DSM Biologics Company Inc.的前董事会成员。他拥有瑞士日内瓦大学MBA、药学理学硕士学位和科学博士学位。他还在同行评审的科学期刊上发表了40多篇原创手稿和通讯。
Francis Bellido has over 36 years of international experience in Cybersecurity, Healthcare and Financial industries. He was the CEO of SoundBite Medical from 2018 to 2020 after serving as CFO from 2015 to 2018. From 2007 to 2014, he held several top executive positions in large, medium sized and start up companies. From 1999 to 2006, he managed a $300M life science investment fund (SGF Santé) and contributed to the success of major companies such as Cryocath, IDI GeneOhm, Draxis, Medicago, Atrium and Axcan Pharma. He also occupied several executive positions with Eli Lilly in the United States and Europe, including Strategic Asset Director, Global Business Unit Manager and Head of Regulatory Affairs. In addition to his corporate roles, he was Director of the Chair of Management in Bioindustry at the University of Quebec in Montreal, where he held the position of Invited Professor at the School of Management for 15 years. Dr. Bellido has served as Board Member and Director in more than 20 private and public companies. He currently sits on the boards of Diagnos (ADK.V), Magneceuticals (USA) and RegenLab (CH). He is also a former board member of DSM Biologics Company Inc., one of the world's leading biopharmaceutical CMOs. He holds an MBA, an MSc in Pharmaceutical Sciences and a PhD in Sciences from the University of Geneva, Switzerland. He has also published over 40 original manuscripts and communications in peer reviewed scientific journals.- Francis Bellido在网络安全、医疗保健和金融行业拥有超过36年的国际经验。他在2015年至2018年担任CFO后，于2018年至2020年担任SoundBite Medical的CEO。从2007年到2014年，他在大型、中型和初创公司担任过多个高管职位。从1999年到2006年，他管理了3亿美元的生命科学投资基金（SGF Sant é），并为Cryocath、IDI GeneOHM、Draxis、Medicago、Atrium和Axcan Pharma等大公司的成功做出了贡献。他还曾在美国和欧洲的礼来担任多个高管职位，包括战略资产总监、全球业务部门经理和监管事务主管。除了担任公司职务外，他还是蒙特利尔魁北克大学生物工业管理系主任，在那里他担任了15年的管理学院特邀教授一职。Bellido博士曾在20多家私营和上市公司担任董事会成员和董事。他目前是Diagnos（ADK.V）、Magneceuticals（USA）和RegenLab（CH）的董事会成员。他还是世界领先的生物制药CMO之一DSM Biologics Company Inc.的前董事会成员。他拥有瑞士日内瓦大学MBA、药学理学硕士学位和科学博士学位。他还在同行评审的科学期刊上发表了40多篇原创手稿和通讯。
- Francis Bellido has over 36 years of international experience in Cybersecurity, Healthcare and Financial industries. He was the CEO of SoundBite Medical from 2018 to 2020 after serving as CFO from 2015 to 2018. From 2007 to 2014, he held several top executive positions in large, medium sized and start up companies. From 1999 to 2006, he managed a $300M life science investment fund (SGF Santé) and contributed to the success of major companies such as Cryocath, IDI GeneOhm, Draxis, Medicago, Atrium and Axcan Pharma. He also occupied several executive positions with Eli Lilly in the United States and Europe, including Strategic Asset Director, Global Business Unit Manager and Head of Regulatory Affairs. In addition to his corporate roles, he was Director of the Chair of Management in Bioindustry at the University of Quebec in Montreal, where he held the position of Invited Professor at the School of Management for 15 years. Dr. Bellido has served as Board Member and Director in more than 20 private and public companies. He currently sits on the boards of Diagnos (ADK.V), Magneceuticals (USA) and RegenLab (CH). He is also a former board member of DSM Biologics Company Inc., one of the world's leading biopharmaceutical CMOs. He holds an MBA, an MSc in Pharmaceutical Sciences and a PhD in Sciences from the University of Geneva, Switzerland. He has also published over 40 original manuscripts and communications in peer reviewed scientific journals.
- Edward Larry Moore
Edward Larry Moore创立了ANACAD，该公司开发了集成电路（IC）设计的软件技术。ANACAD的产品在IC设计中的应用被全球采用，并被戴姆勒、东芝、SGS汤姆森等大公司所采用。该公司最终被出售给了明导资讯。Moore博士目前是Baystream的总裁，该公司是一家专注于过程自动化和基于云的解决方案的公司。最近，Baystream开发了自动化解决方案，将专注于可用性和合规性的安全强化系统部署到云上，从而加强了其流程自动化产品及其在市场上的关键地位。
Edward Larry Moore founded ANACAD, which developed software technology for integrated circuit (IC) design. ANACAD's products were adopted globally for their application in IC design and utilized by major corporations such as Daimler, Toshiba, and SGS Thomson. The company was eventually sold to Mentor Graphics. Dr. Moore is currently President of Baystream, a company specializing in process automation and cloud based solutions. Recently, Baystream developed automation solutions to deploy security hardened systems to the Cloud that are focused on availability and compliance, strengthening its process automation offering and its key position in the market.- Edward Larry Moore创立了ANACAD，该公司开发了集成电路（IC）设计的软件技术。ANACAD的产品在IC设计中的应用被全球采用，并被戴姆勒、东芝、SGS汤姆森等大公司所采用。该公司最终被出售给了明导资讯。Moore博士目前是Baystream的总裁，该公司是一家专注于过程自动化和基于云的解决方案的公司。最近，Baystream开发了自动化解决方案，将专注于可用性和合规性的安全强化系统部署到云上，从而加强了其流程自动化产品及其在市场上的关键地位。
- Edward Larry Moore founded ANACAD, which developed software technology for integrated circuit (IC) design. ANACAD's products were adopted globally for their application in IC design and utilized by major corporations such as Daimler, Toshiba, and SGS Thomson. The company was eventually sold to Mentor Graphics. Dr. Moore is currently President of Baystream, a company specializing in process automation and cloud based solutions. Recently, Baystream developed automation solutions to deploy security hardened systems to the Cloud that are focused on availability and compliance, strengthening its process automation offering and its key position in the market.
- John Young
约翰·杨看电影《能抓住我就抓住我》十几岁的时候，三年时间里，约翰·杨和他的电信系统专家导师、已故的D.F.鲁尼，成功地入侵了美国电话电报网络——直到FBI吓得他直接进入了40年的网络安全生涯。作为麦道价值410亿美元的C17项目的前网络总监，约翰后来在IBM工作了几十年后退休，随后成为全球仅有的11位获得全部9项ISC2认证的网络安全专家之一。于2024年6月被任命为QEM的董事会成员。
John Young see the movie Catch Me If You Can As a teenager, for three years John Young and his expert telecommunications systems mentor, the late D.F. Rooney, successfully hacked the AT&T network—until the FBI scared him straight into a 40 year cybersecurity career. The former network director of McDonnell Douglas's $41 billion C 17 program, John later retired after decades at IBM and then became one of only 11 cybersecurity experts worldwide to earn all nine ISC2 certifications. Named to the board of directors at QeM in June 2024.- 约翰·杨看电影《能抓住我就抓住我》十几岁的时候，三年时间里，约翰·杨和他的电信系统专家导师、已故的D.F.鲁尼，成功地入侵了美国电话电报网络——直到FBI吓得他直接进入了40年的网络安全生涯。作为麦道价值410亿美元的C17项目的前网络总监，约翰后来在IBM工作了几十年后退休，随后成为全球仅有的11位获得全部9项ISC2认证的网络安全专家之一。于2024年6月被任命为QEM的董事会成员。
- John Young see the movie Catch Me If You Can As a teenager, for three years John Young and his expert telecommunications systems mentor, the late D.F. Rooney, successfully hacked the AT&T network—until the FBI scared him straight into a 40 year cybersecurity career. The former network director of McDonnell Douglas's $41 billion C 17 program, John later retired after decades at IBM and then became one of only 11 cybersecurity experts worldwide to earn all nine ISC2 certifications. Named to the board of directors at QeM in June 2024.